RESEARCHERS at the University of North Carolina say that women with a family history of breast cancer should be "strongly encouraged" to breastfeed.
14/08/2009
Melbourne researchers have received AUD$1.5 million to investigate whether breast stem cells or their descendents are directly linked to breast cancer, in the hope of leading to new treatments for the disease.
07/12/2009
ACCORDING to a report by Nehmat Houssami in the Annals of Oncology, women who survived a primary breast cancer were more likely to survive a subsequent case if detected early.
20/03/2009
NEW guidelines have been released for physicians using magnetic resonance imaging (MRI) to diagnose and make treatment decisions for breast cancer.
17/02/2009
US researchers have shown that circulating glucose and insulin may play a role in breast cancer in postmenopausal women. By analysing baseline levels of these compounds in plasma, they demonstrated that elevated serum levels may prove to be a risk factor.
22/10/2009
RESEARCHERS at the Austrian Breast & Colorectal Cancer Study Group (ABCSG) have found a bone metastases prevention drug reduces the risk of breast cancer recurrence in premenopausal women.
14/02/2009
Life Technologies has announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression.
16/04/2010
THE BRITISH Medical Journal has released a paper which discusses the ethics of young women being screened for breast cancer after a cosmetic surgery procedure without their informed consent.
13/03/2009
US researchers have shown how a microRNA, a short RNA molecule that regulates the activity of genes, called miR-9 may be important in a breast tumours’ ability to spread to other parts of the body and gather nutrients to survive and grow.
24/02/2010
SCIENTISTS at the American National Cancer Institute have determined an important link between inherited factors and the progression of breast cancer into the metastatic stage during a recent study in mice.
14/01/2009
Life Technologies is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumours have progressed despite multiple other therapies. The goal of this research is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals.
15/03/2010
FURTHER to its work with the University of Pittsburgh, PGxHealth has announced its research collaboration with the Dana-Farber Cancer Institute (DCFI) to validate the use of genetic variants in Fc gamma receptors (FCGRs), in predicting response to trastuzumab (Herceptin) therapy in patients with breast cancer.
21/05/2009
BREASTSCREEN Australia has voiced its concern over the use of imaging services promising pain-free breast cancer screening without radiation.
07/08/2009
DATA Scientists says it has debuted its open-source OccIDEAS software for health researchers.
09/07/2009
THE ANNE Rita Monahan Foundation will host a high English afternoon tea in efforts to raise funds for ovarian cancer research on 28 Febuary 2009 at Sheraton Downtown Pheonix at 2pm.
17/02/2009
A RESEARCHER with the University of Missouri is developing a device to analyse breath or urine samples to detect breast cancer, lung cancer, diabetes or asthma.
20/03/2009
THE TRANSLATIONAL Genomics Research Institute (TGen) has announced plans o organise a cancer awareness conference for northeastern Arizona’s vast Navajo Nation.
08/04/2009
RESEARCHERS at the University of Massachusetts Amherst have developed a ‘chemical nose’ array of nanoparticles and polymers to detect cancer earlier.
25/06/2009
RESEARCHERS at the University of California, Santa Cruz have developed a Cancer Genomics Browser which provides a new way to visualise and analyse data from studies aimed at improving cancer treatment by unravelling the complex genetic roots of the disease.
02/04/2009
A NEW DRUG designed to “seek and destroy” common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.
06/10/2009